Femoral Vascular Access: Technique, Closure Devices, and Complications
|
|
|
- Allyson King
- 9 years ago
- Views:
Transcription
1 TCT 2011 November 7-11, 2011 Femoral Vascular Access: Technique, Closure Devices, and Complications Robert J Applegate, M.D. Professor of Internal Medicine-Cardiology
2 Disclosures Advisory Board Research Grants Abbott Vascular Abbott Vascular St Jude Medical Consultant Terumo Corporation Abbott Vascular St Jude Medical
3 Choosing the Vascular Access Site Determine type of procedure/sheath size needed Coronary Renal, ilio-femoral Infra-inguinal Support devices; percutaneous AV Consider access sites-any limitations/obstructions Femoral Brachial Radial Co-morbid illnesses/diseases CKD; PVD Bleeding risk
4 Vascular Access Overview Femoral Brachial Radial (6-9 mm) (4-7 mm) (3-5 mm) Ease of access Learning curve short some yes Flexibility in sheath size Anticoagulation (cath) no yes yes Complication rates
5 Femoral Artery Access Optimal access- Above bifurcation Below inferior epigastric artery Courtesy Dr Z Turi
6 Femoral Artery Access Landmarks/strategies for achieving access Inguinal crease Bony landmarks Floroscopy over femoral head Doppler guided Ultrasound guided
7 Femoral Artery Access Can you pick out the skin crease?? Courtesy Dr Z Turi
8 Femoral Artery Access Double fluoroscopy technique: Identify skin entry site over femoral head with hemostats Re-assess needle entry site just before entering artery Best chance to hit target zone
9 Ultrasound Guided Femoral Artery Access Better resolution, and depth than possible previously Site-Rite5, Bard Access, Inc. 18g needle guide #9001C0212 Courtesy Dr A Seto
10 Ultrasound Guided Femoral Artery Access Better resolution, and depth than possible previously Site-Rite5, Bard Access, Inc. 18g needle guide #9001C0212 Courtesy Dr A Seto
11 Femoral Artery Access Sticking until you hit the artery is not a sound or safe strategy! Good access will allow good closure Fellows in July The patient is NOT a pin cushion!! Courtesy Drs Z Turi, And J Hermiller
12 Femoral Artery Access Front wall stick desirable-micropuncture desirable Pulsatile flow before advancing wire Wire exits needle without resistance-don t push Gain familiarity with exchange catheters Gain familiarity with hydrophilic wires Don t be afraid to ask for help
13 Femoral Access Site Closure Manual Compression The gold standard; but competency often taken for granted A patient s perspective An attending s perspective
14 Femoral Artery Closure Manual Compression Works Best when CFA Accessed Courtesy Dr Z Turi
15 Limitations of Manual Compression Delayed ambulation Patient dissatisfaction/discomfort Time and personnel intensive Vascular complications in anticoagulated pts after successful hemostasis still occur
16 Vascular Closure Devices VCDs clinically introduced 1994-Vasoseal, and Perclose; Angioseal introduced in 1996 Addressed need for more aggressive anticoagulation and larger bore sheaths for 1st gen stents and atherectomy Early devices failed 10-20% of time Device modifications (x 8) have stream lined and simplified use, and substantially reduced failures
17 Anatomic Requirements per IFU Closure Devices Common femoral artery (CFA) access location Minimal lumen diameter CFA 4-6 mm (device specific) Absence of severe ASCVD Absence of severe calcification Need femoral angiogram before deployment! 2011 Buyers Guide Endovascular Today
18 Current FDA Approved Closure Devices Vendor Product Closure Method Abbott Vascular Perclose AT Suture Perclose Proglide Suture Perclose ProStar XL Suture Starclose SE Nitinol clip Access Closure Mynx Cadence Extravascular PEG sealant Arstasis Arstasis One Reentry closure Cardiva Medical Boomerang Catalyst III Arteriotomy tampanode Cordis Exoseal Extravascular PGA plug Morriss Innovative FISH SIS arterial plug St Jude Medical Angio-Seal VIP Mechanical seal Angio-Seal Evolution Interventional Therapies QuickClose Suture and knot Nobles Medical Super Stitch Suture and knot Vascular Solutions Duett Pro Thombin/collagen pro-coagulant 2011 Buyers Guide Endovascular Today
19 Mechanism of Closure Closure Devices Active approximation-angio-seal; Perclose; QuickClose; Starclose Passive closure (extravascular)-duett; Exoseal; Mynx; VasoSeal Facilitated manual compression-arstasis; Catalyst Novel- FISH Patch-D-Stat; Neptune; Syvek; etc 2011 Buyers Guide Endovascular Today
20 Boomerang Catalyst Consider for non CFA sites when manual compression may be challenging Catalyst III Protamine coated
21 Arstasis O Going TCT 2009
22 FISH (Femoral Introducer and Sheath Hemostasis Device) SIS Small Intestinal Submucosa (porcine) Self sealing concept Limited clinical data 3 R Patioloa TCT 2009
23 Mynx * Bioabsorbable PEG
24 Seal arteriotmy 1 2 Extra vascular closure Consider for non CFA closure Expose PEG Remove device 3 Tissue tract
25 Exoseal Bioabsorbable PGA Introduce through existing sheath Identify vessel wall Unsheath vascular plug Brief manual compression
26 Perclose
27 Perclose ProGlide/Prostar Now VCD of choice for large sheath closure
28 Starclose SE * a From the case control portion of the study only (analysis of other variables was from the entire patient cohort).
29 StarClose
30 Angio-Seal * * a From the case control portion of the study only (analysis of other variables was from the entire patient cohort).
31 Angio-Seal Evolution Anchor Set Ease of use made it market leader Gear Mechanism Designed with precision engineering to rotate as the device is pulled back by the user. Accurately manages the compressive sealing force. Standardized Deployment Rack Precisely engineered for forward movement while user pulls back on the device. This forward movement guides the compaction tube forward. Automated Collagen Compaction Automated Compaction Rack Engaged Consistent compaction force
32 Optimize Use of VCDs Take the time to learn how to use closure devices Commit to a device and gain expertise with it Follow the guidelines for use and perform femoral angios prior to all deployments Monitor your outcomes VCDs may fail; become occlusive; or infected Be vigilant and recognize these potential complications
33 Anatomic Challenges in Using Low or bifurcation stick High stick VCDs Significant ASCVD of CFA Significant calcification of CFA Prior VCD use Severe angulation of sheath entry
34 Factors that Influence Outcome of VCD Use Patient characteristics Anticoagulation and anti-platelet therapy Procedure type Access site anatomy Device features and performance Operator and institutional experience
35 Evaluation of Outcomes with Vascular Closure Devices Not one large randomized clinical trial of closure device vs manual compression!! No compelling evidence that 1st generation VCDs lower rates of vascular complications No convincing evidence that one VCD is better than another; although data support notion that Vasoseal was harmful (compared to manual)
36 Evaluation of Outcomes with 1 st gen Vascular Closure Devices Meta-analyses of outcomes with VCDs (mainly 1 st gen devices) Manual compression may be safer Koreny et al JAMA 2004;4291:350 Manual compression may be safer Nikolsky et al JACC 2004;44:1200
37 Vascular Closure Devices There is a substantial learning curve with VCDs! Greater experience, multiple modifications of VCDs benefitting efficacy and safety! Balzer et al CCI 2001; 53:
38 Studies with 10,000 or More Patients: VCD vs Manual Compression Study Complication Rates Year published # patients Study type Endpoint VCD MC P Value Nikolsky ,066 Trial and Registry Meta- Analysis Hematoma OR 1.34 CI P <.05 Tavris ,680 National Registry (NCDR) any VC 1.10% 1.70% P<0.001 Tavris ,878 National Registry (NCDR) any VC OR 0.99 CI P=ns Arora ,937 Single Center Registry any VC 2.40% 4.90% P < 0.01 Ahmed ,563 Multicenter registry Bleeding/VC OR: 0.72 CI P=0.02 Applegate ,016 Single Center Registry any VC 1.60% 2.10% P=0.03 Sanborn ,621 ACUITY post hoc Access site bleeding 2.50% 3.30% P=0.01 Marso ,522,935 National Registry (NCDR) Peri-procedural OR: 0.77 CI P < 0.05 OR= odds ratio bleeding Dauerman et al JACC 2011; 58:1-10
39 Strategy of VCD and Bivalirudin vs Compression VCD-4307 no VCD=7,314 ACC NCDR 300,000 high risk PCI pts 62% Marso et al JAMA 2010; 303:
40 Types of Vascular Complications after Femoral Artery Access Hematoma * A-V fistulae Psuedoaneurym Occlusion RPH Infection * Nerve Injury * Courtesy Dr Z Turi
41 Incidence of Vascular Complications after Femoral Artery Access Vascular Wake Forest ACC-NCDR Turi White Complication(%) ( ) (2001) (2004) (2004) Bleeding <3 RP bleed Vascular repair Infection <1 <0.2 Death Hematoma <6 Pseudoaneursym A-V fistulae <1 <0.4
42 Why Do (femoral) Vascular Complications Persist? Anatomic Stick location; femoral vs radial; vessel size; PVD Procedural Poor puncture technique ; PCI; multiple procedures; anticoagulation; GPI Closure Patient Clinical Manual compression vs VCD use Very thin or obese; gender; renal disease Emergency procedure; shock; AMI
43 VCD Specific Complications Device failure in anti-coagulated patient to Unable remove device from artery/groin Embolization of device into artery Foreign body reaction to device Infection Nerve entrapment
44 Iliac Artery or High Sticks Angiography CT Scan *
45 Closure Device use in High Stick? Cause for Concern Risk of RPH VCD compared to manual compression Study OR 95% CI Farouque Ellis Tiroch Farouque et al JACC 2005; 45(3): ; Ellis et al CCI 2006; 67: ; Tiroch et al CCI 2007; TCT 2007
Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005
Complications of Femoral Catheterization Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005 Case Presentation xx yr old female presents with fever, chills, and painful swelling of R groin
ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE INSTRUCTIONS FOR USE
ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE INSTRUCTIONS FOR USE TO ENSURE PROPER DEPLOYMENT AND USE OF THIS DEVICE AND TO PREVENT INJURY TO PATIENTS, READ ALL INFORMATION CONTAINED IN THESE INSTRUCTIONS
Femoral Artery Closure After Cardiac Catheterization
Femoral Artery Closure After Cardiac Catheterization Wallace J. Hamel Crit Care Nurse 2009;29:39-46 doi: 10.4037/ccn2009157 2009 American Association of Critical-Care Nurses Published online http://www.cconline.org
12276408.3. Instructions for Use Cordis EXOSEAL TM VASCULAR CLOSURE DEVICE
12276408.3 Instructions for Use Cordis EXOSEAL TM VASCULAR CLOSURE DEVICE Figure 1: Components of the EXOSEAL TM Vascular Closure Device 1. Handle Assembly 2. Plug Deployment Button 3. Indicator Window
Imaging of Thoracic Endovascular Stent-Grafts
Imaging of Thoracic Endovascular Stent-Grafts Tariq Hameed, M.D. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana Disclosures: No relevant financial
A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair
A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair Table of Contents The AFX Endovascular AAA System............................................ 1 What is an Abdominal Aortic Aneurysm
Local Coverage Article: Endovascular Repair of Aortic Aneurysms (A53124)
Local Coverage Article: Endovascular Repair of Aortic Aneurysms (A53124) Contractor Information Contractor Name Novitas Solutions, Inc. Article Information General Information Article ID A53124 Original
Patient Information Booklet. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms
Patient Information Booklet Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms TABLE OF CONTENTS Introduction 1 Glossary 2 Abdominal Aorta 4 Abdominal Aortic Aneurysm 5 Causes 6 Symptoms
REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES
REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES Effective January 1, 2015, there was a change in CPT that affects reporting specific endovascular services provided in the
Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery?
KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery? Liz Paxton Director of Surgical Outcomes and Analysis Overview KP Total Joint Replacement Registry Background
Right Heart Catheterization from the Arm
Right Heart Catheterization from the Arm Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine 1 Disclosure Statement of Financial Interest Within the
Tunneled Hemodialysis Catheters: Placement and complications
Tunneled Hemodialysis Catheters: Placement and complications Arif Asif, M.D. Director, Interventional Nephrology Associate Professor of Medicine University of Miami, FL Tunneled Hemodialysis Catheters:
Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach
Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Bao- Thuy D. Hoang, MD 1, Jonathan- Hien Vu, MD 2, Jerry Matteo, MD 3 1 Department of Surgery, University of Florida College of Medicine,
Talent Thoracic Stent Graft with THE Xcelerant Delivery System. Expanding the Indications for TEVAR
Talent Thoracic with THE Xcelerant Delivery System Expanding the Indications for TEVAR Talent Thoracic Precise placement 1 Broad patient applicability 1 Excellent clinical outcomes 1, a + Xcelerant Delivery
PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf
Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page)
Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) The Kidney and the Renal Arteries... 1 Renal Artery Disease... 2 Diagnosis of Renal.Artery Disease...
Endovascular Bar Code Product Catalog
1012528-100 Absolute Pro Self-Expanding Stent System 6.0 mm x 100 mm x 80 / (01) 0 8717648 17557 2 1012528-20 Absolute Pro Self-Expanding Stent System 6.0 mm x 20 mm x 80 / (01) 0 8717648 17552 7 1012528-30
FFR CT : Clinical studies
FFR CT : Clinical studies Bjarne Nørgaard Department Cardiology B Aarhus University Hospital Skejby, Denmark Disclosures: Research grants: Edwards and Siemens Coronary CTA: High diagnostic sensitivity
The treatment of peripheral vascular disease has
Covered s in Peripheral Vascular Aneurysms and Emergencies Reviewing current covered stent selection and use through case study and discussion. By Alberto Posabella, MD; Raffaele Rosso, MD, FACS, FRCS;
Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need
Listen to Your Heart The S-ICD System What Everyone Needs To Know About Atrial Fibrillation & Stroke The protection you need without Stroke. touching Are you your at heart risk? Increase your knowledge.
Percutaneous closure of paravalvular leaks EULOGIO GARCIA MD MADRID ~ SPAIN
Percutaneous closure of paravalvular leaks EULOGIO GARCIA MD MADRID ~ SPAIN BACKGROUND The incidente of paravalvular leaks is variable ( from 2% up to 17% ). More frequent in mechanical valves. Surgical
RADIOLOGY 2014 CPT Codes
RADIOLOGY 2014 CPT Codes Radiology 2014 CPT Codes CMS has issued 36 new procedure codes (one is a radiation therapy code) for CY 2014 that directly pertain to radiology with 26 of those codes the result
Groin Dressing post Cardiac Catheterization: Traditional pressure Versus Transparent Film. BSN, MSN, Clinical nursing, Critical Care Nursing
Groin Dressing post Cardiac Catheterization: Traditional pressure Versus Transparent Film BSN, MSN, Clinical nursing, Critical Care Nursing Introduction Transfemoral percutaneous coronary procedures have
Atherosclerosis of the aorta. Artur Evangelista
Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis
X-Plain Subclavian Inserted Central Catheter (SICC Line) Reference Summary
X-Plain Subclavian Inserted Central Catheter (SICC Line) Reference Summary Introduction A Subclavian Inserted Central Catheter, or subclavian line, is a long thin hollow tube inserted in a vein under the
Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?
Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital
Overview of Newer Stent Devices for Aneurysm Treatment
Overview of Newer Stent Devices for Aneurysm Treatment Randall C. Edgell, M.D. Associate Professor Vascular and Interventional Neurology Saint Louis University Disclosure Outcome adjudication for THERAPY,
Ultrasound in Vascular Surgery. Torbjørn Dahl
Ultrasound in Vascular Surgery Torbjørn Dahl 1 The field of vascular surgery Veins dilatation and obstruction (varicose veins and valve dysfunction) Arteries dilatation and narrowing (aneurysms and atherosclerosis)
Instructions for Use. Device Description The AMPLATZER Vascular Plug II is a self-expandable nitinol mesh occlusion device (see Figure 1).
Vascular Plug II Instructions for Use Device Description The AMPLATZER Vascular Plug II is a self-expandable nitinol mesh occlusion device (see Figure 1). A B Figure 1. AMPLATZER Vascular Plug II A. Nitinol
Minimally Invasive Spine Surgery
Chapter 1 Minimally Invasive Spine Surgery 1 H.M. Mayer Primum non nocere First do no harm In the long history of surgery it always has been a basic principle to restrict the iatrogenic trauma done to
Cilostazol versus Clopidogrel after Coronary Stenting
Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background
JUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JUL 2 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular
Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009
Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 I. Overview of Training in Cardiac Catheterization Cardiac catheterization
Majestic Trial 12 Month Results
Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.
Policies and Procedures. Related to. IABP Therapy
Policies and Procedures Related to IABP Therapy Courtesy of Datascope Corp. Clinical Support Services The following policies and procedures are intended to serve as guidelines for developing hospital policy.
None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015
Financial Disclosure Information Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management Robert D. McBane, M.D. Division of Cardiology Mayo Clinic Rochester Dual Antiplatelet
Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,
Instructions For Use Aorfix AAA Flexible Stent Graft System
Instructions For Use AAA Flexible Stent Graft System With AorFlex Delivery Device Caution: Federal law (USA) restricts this implant to sale by or on the order of a physician. Page 1 of 62 PN02114 Issue
PERCUTANEOUS PD CATHETER IMPLANTATION SYSTEM
Place on Patient s Cranial Border of the Pubic Symphysis IMPLANTATION STENCIL Classic Exit Cuff Site PERCUTANEOUS PD CATHETER IMPLANTATION SYSTEM INSTRUCTIONS FOR USE VP 511 and VP-511M Implantation System
Coronary Arteries: Number of Vessels/Number of Stents
Coronary Arteries: Number of Vessels/Number of Stents Issue Should code table 027 be revised to capture the number of coronary vessels treated and/or the number of coronary stents inserted? New Technology
How To Determine Pad
Process Representation #1 : The PAD algorithm as a sequential flow thru all sections An exploded version of the above scoped section flow is shown below. Notes: The flow presupposes existing services (
Orsiro Hybrid Drug Eluting Stent Industry's first hybrid DES
Vascular Intervention Drug Eluting Stents Orsiro Orsiro Hybrid Drug Eluting Stent Industry's first hybrid DES Orsiro An ideal combination of passive and active components The Orsiro Hybrid Drug Eluting
The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment
LAA Occlusion Therapy The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment John Carroll, MD University of Colorado Interventional 3-D Lab 3-D Research Lab for Interventions
Hemostasis Solutions Boston Scientific is committed to improving patient care in the management of gastrointestinal bleeding.
Hemostasis Solutions Boston Scientific is committed to improving patient care in the management of gastrointestinal bleeding. Through innovation and continuous educational support, we offer a wide range
FEMORAL ARTERY SHEATH MANAGEMENT
Centre for Education & Practice Development Learning Module FEMORAL ARTERY SHEATH MANAGEMENT For Registered Nurses Division 1 February 2008 Acknowledgment This document has been compiled utilising the
Purpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing.
Purpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing. Qualifications To be eligible for core privileges in the Department of Cardiology,
PATIENT INFORMATION BOOKLET
PATIENT INFORMATION BOOKLET Wingspan Stent System with Gateway PTA Balloon Catheter TABLE OF CONTENTS Definitions... 2 What is the Purpose of This Booklet?... 3 What is an Intracranial Lesion?... 3 Who
Duration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
Liau DW : Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis. ASA Newsletter 70(6): 11-13 & 16, 2006.
Citation Liau DW : Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis. ASA Newsletter 70(6): 11-13 & 16, 2006. Full Text An anesthesiologist inserted a 14-gauge peripheral
1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia
PUBLICATIONS, ABSTRACTS AND PRESENTATIONS : 1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia 2. Endovascular management of the suprarenal IVC agenesis 3. The
Is There A LIfe for DES after discontinuation of Clopidogrel
Chicago 2014 Is There A LIfe for DES after discontinuation of Clopidogrel Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin:
Complete Guide for Interventional Radiology
2013 Complete Guide for Interventional Radiology Contents Introduction... 1 CPT Codes and Descriptions...1 Procedure Codes...2 Chapter 1: The Basics... 5 APC Basics Why Is This Important?...5 CCI Edits
Oxford Centre for Respiratory Medicine Bronchial-Artery Embolisation Information for patients
Oxford Centre for Respiratory Medicine Bronchial-Artery Embolisation Information for patients This leaflet tells you about the bronchial-artery embolisation procedure. It explains what is involved and
Medical Education Policy: Central Venous Catheter (CVC) Placement
Medical Education Policy: Central Venous Catheter (CVC) Placement Facility: CMC Origin Date: June 2015 Revision Date: Sponsor: GMEC 1. PURPOSE: Carilion Clinic is committed to excellent patient care, with
TREATMENT OF VARICOSE VEINS: CAN IT BE IMPROVED BY MECHANOCHEMICAL ABLATION USING THE CLARIVEIN DEVICE?
TREATMENT OF VARICOSE VEINS: CAN IT BE IMPROVED BY MECHANOCHEMICAL ABLATION USING THE CLARIVEIN DEVICE? Michel MJP Reijnen Rijnstate Hospital, Arnhem The Netherlands [email protected] Disclosures
Coronary angiogram : An author view Patwary MSR
The ORION Medical Journal 2008 Sep;31:599-601 Coronary angiogram : An author view Patwary MSR Abstract It is relatively safe, though minimally invasive, test. Coronary angiogram is an x-ray of the coronary
Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI
Ostial LAD: Single stent approach is the best Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Chair, Interventional Cardiology Sanatorio San Lucas Instituto Alexander Fleming Buenos
Mesenteric Angiography
Information for patients Mesenteric Angiography Sheffield Vascular Institute Northern General Hospital You have been given this leaflet because you need a procedure known as a Mesenteric Angiogram. This
Policies & Procedures. I.D. Number: 1073
Policies & Procedures Title:: CENTRAL VENOUS CATHETERS INSERTION ASSISTING I.D. Number: 1073 Authorization [] Pharmacy Nursing Committee [] MAC Motion #: [x] SHR Nursing Practice Committee Source: Nursing
Antonio Colombo MD on behalf of the SECURITY Investigators
Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY
A PATIENT S GUIDE TO CARDIAC CATHETERIZATION
A PATIENT S GUIDE TO CARDIAC CATHETERIZATION The science of medicine. The compassion to heal. This teaching booklet is designed to introduce you to cardiac catheterization. In the following pages, we will
Reporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013
Reporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013 There are nine new CPT codes effective January 1, 2013, for reporting TAVR procedures. Five of these codes are Category I codes
Components of CVC Care Bundle. selection
Components of CVC Care Bundle Catheter site selection Site of insertion influences the subsequent risk for CR-BSI and phlebitis The influence of site is related in part to the risk for thrombophlebitis
Aneurysm Embolization System for the Treatment of Cerebral Aneurysms. Information for Patients and Families
this booklet is provided for for any non emergency questions, contact us at Aneurysm Embolization System for the Treatment of Cerebral Aneurysms Information for Patients and Families 2 3 Information for
Clinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute
Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical
Section 4: Your Vascular Access. What is vascular access?
Section 4: Your Vascular Access What is vascular access? What is a fistula? Taking care of a new fistula What is a graft? Taking care of a new graft What is a hemodialysis catheter? Taking care of a hemodialysis
What You Should Know About Cerebral Aneurysms
What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,
Surgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart
Surgical Options for Venous Disease Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Chronic Venous Disease Approximately 23% of adults in the US have varicose veins Estimated 22 million women
Coding for Peripheral Vascular Disease (PVD)
Coding for Peripheral Vascular Disease (PVD) Audio Seminar/Webinar August 20, 2009 Practical Tools for Seminar Learning Copyright 2009 American Health Information Management Association. All rights reserved.
WallFlex Biliary RX Stent. Fully, Partially and Uncovered Self-Expanding Metal Stents
WallFlex Biliary RX Stent Fully, Partially and Uncovered Self-Expanding Metal Stents WallFlex Biliary RX Stent Fully, Partially and Uncovered Self-Expanding Metal Stents The WallFlex Biliary RX Stent is
Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty
Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor
Choice of guiding catheters and guidewires
Choice of guiding catheters and guidewires Dr. Ahmad Elsayed Yousef, MD Lecturer of Cardiology, Ain Shams University Werner Frossmann-1929 1 X-ray for angioraphy (1950-1970) Cine frame from the first selective
Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC
Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC 2015 Edition All Reimbursement Amounts are Listed at National Rates and Do Not Include the 2% Sequestration
Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases
Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases T. Masood,T. Sagheer,D. Jan,N. Qamar,A.M.A. Faruqui ( National Institute of Cardiovascular Diseases (NICVD), Karachi.
Colocutaneous Fistula. Disclosures
Colocutaneous Fistula Madhulika G. Varma MD Associate Professor Chief, Colorectal Surgery University of California, San Francisco Honoraria Applied Medical Covidien Disclosures 1 Colocutaneous Fistula
Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam
Drug-Eluting Balloons Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Potential conflicts of interest Speaker s name: Klaus Bonaventura
SCREENING COMPRESSION ULTRASOUND FOR LOWER EXTREMITY DVT
SCREENING COMPRESSION ULTRASOUND FOR LOWER EXTREMITY DVT R. Eugene Zierler, M.D. The D. E. Strandness, Jr. Vascular Laboratory University of Washington Medical Center Division of Vascular Surgery University
MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE
DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:
Inferior Vena Cava filter and removal
Inferior Vena Cava filter and removal What is Inferior Vena Cava Filter Placement and Removal? An inferior vena cava filter placement procedure involves an interventional radiologist (a specialist doctor)
RELAY Plus Thoracic Stent-Graft System with Transport Delivery System
RELAY Plus Thoracic Stent-Graft System with Transport Delivery System TABLE OF CONTENTS Section Page DEVICE DESCRIPTION 8 RADIOPAQUE MARKER BANDS 8 RELAY PLUS TRANSPORT DELIVERY SYSTEM 8 INDICATIONS FOR
New Anticoagulants and GI bleeding
New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit
Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions
Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions Andrejs Erglis, Sanda Jegere, Zanda Runkule, Ligita Zvaigzne, Dace
Coronary Stents. What is a Coronary Artery stent?
What is a Coronary Artery stent? Coronary Stents A coronary stent is stainless tube with slots. It is mounted on a balloon catheter in a "crimped" or collapsed state. When the balloon of is inflated, the
Non-surgical treatment of severe varicose veins
Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in
SUPPLEMENTARY MATERIALS. Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial
1 SUPPLEMENTARY MATERIALS Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial Professor Ka Sing Lawrence Wong on behalf of The Executive Steering Committee and the ROCKET
This means you! Appropriate training, supervision and procedural load is what determines outcome not clinician grade! Studies have shown that a clinic
PROMOTING VESSEL HEALTH & PRESERVATION: The RIGHT trained clinician will insert: The RIGHT vascular device in the: The RIGHT vessel for the: The RIGHT patient at the: The RIGHT time This means you! Appropriate
Chapter 6. Hemorrhage Control UNDER FIRE KEEP YOUR HEAD DOWN
Hemorrhage Control Chapter 6 Hemorrhage Control The hemorrhage that take[s] place when a main artery is divided is usually so rapid and so copious that the wounded man dies before help can reach him. Colonel
Angioplasty and Stent Education Guide
Angioplasty and Stent Education Guide Table of Contents Treating coronary artery disease...2 What is coronary artery disease...3 Coronary artery disease treatment options...4 What are coronary artery
Advances in Stent Technology
Nurse/Technologist Symposium Advances in Stent Technology Antonietta Tolentino, CCRN, MSN, ANP-C Adult Nurse Practitioner, Cardiac Catheterization Laboratory The Zena and Michael A. Weiner Cardiovascular
Measuring ROI Based on Procedure and Reimbursement Rate
Measuring ROI Based on Procedure and Reimbursement Rate Dee Whittington RN BSN CNOR Clinical Supply Consultant Gregg Lauder MBA CMRP Senior Capital Director www.acesummitandexpo.com Topics to Cover Analyze
